Edgewood Oncology Inc.
Edgewood Oncology Inc.
Explore linked clinical trials.3 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| BTX-A51 in Patients With Liposarcoma or CIC-rearranged Sarcoma | CIC-rearranged sarcoma, Neoplasms by Histologic Type, Neoplasms, Adipose Tissue, Neoplasms, Connective and Soft Tissue, liposarcoma, myxoid liposarcoma, neoplasm, sarcoma | Active, not recruiting | Phase 1 | 2026-07-01 | NCT06414434 | |
| A Study of BTX-A51 in People With Advanced Solid Tumor and Breast Cancer | Neoplasms by Site, Skin and Connective Tissue Diseases, breast disorder, breast neoplasm, neoplasm, skin disorder | Recruiting | Phase 1 | 2025-01-30 | NCT04872166 | |
| A Study of BTX-A51 in People With Relapsed or Refractory Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, acute myeloid leukemia, bone marrow disorder, hematologic disorder, leukemia, myelodysplastic syndrome, myeloid leukemia, neoplasm | Recruiting | Phase 1 | 2024-03-20 | NCT04243785 |